|
Originally published In Press as doi:10.1074/jbc.M105871200 on August 8, 2001
J. Biol. Chem., Vol. 276, Issue 42, 38441-38448, October 19, 2001
The Fused Protein Kinase Regulates Hedgehog-stimulated
Transcriptional Activation in Drosophila Schneider 2 Cells*
Takahiro
Fukumoto ,
Rie
Watanabe-Fukunaga,
Kyoko
Fujisawa,
Shigekazu
Nagata, and
Rikiro
Fukunaga§
From the Department of Genetics, B-3, Osaka University Medical
School, and Core Research for Evolutional Science and Technology, Japan
Science and Technology Corporation, 2-2 Yamadaoka, Suita,
Osaka 565-0871, Japan
Received for publication, June 25, 2001, and in revised form, August 7, 2001
 |
ABSTRACT |
The Drosophila segment polarity gene
fused encodes a putative protein-serine/threonine kinase,
and plays a critical role in the signal transduction for Hedgehog
(Hh)-dependent gene expression. We show that the
Drosophila Schneider 2 (S2) cell line has the potential to
transduce the Hh-triggered intracellular signals, leading to the
activation of target gene expression, when a transcription factor,
Cubitus interruptus (Ci), is provided exogenously. Using S2 cells
transfected with the Ci-expressing plasmid and a patched promoter reporter construct, we demonstrate that the forced expression of Fused (Fu) stimulates Hh-triggered and Ci-dependent
transcriptional activation. The N-terminal kinase domain of Fu is
required for this activity, but the C-terminal domain is not. Two
kinase-inactive Fu mutants fail to enhance the reporter activation,
indicating that the kinase catalytic activity is essential for this
function. Negative components of the Hh-signaling pathway, Costal-2 and Suppressor of Fused, strongly antagonize the Fu activity, irrespective of the presence or absence of the Fu C-terminal domain, suggesting an
indirect mechanism for the inhibition of Fu by these proteins. Furthermore, mutational analyses of threonine 158 and serine 159, in
the activation segment of the Fu protein kinase, indicate that threonine 158 is essential for Fu activity and that phosphorylation of
this threonine residue may be involved in the activation of the
kinase catalytic activity upon Hh stimulation.
 |
INTRODUCTION |
The Hedgehog (Hh) family of secreted factors controls a wide
variety of developmental processes in both vertebrates and
invertebrates by regulating the proliferation and differentiation of
target cells. Drosophila Hh, which was originally identified
as a segment polarity gene product, is required for patterning
embryonic segment and adult structures such as wing, legs, and eyes
(1-3). In mammals, three Hh homologs, Sonic, Desert, and Indian
hedgehog, are expressed in a tissue-specific manner and are responsible
for morphogenesis of the neural tubes, somites, and other organs (4,
5). The mammalian Hh signaling pathway is also involved in the
tumorigenesis of basal cell carcinoma (5, 6).
Hh is synthesized as a precursor protein and processed by the
autoproteolytic and cholesterol-conjugating activity of its C-terminal
domain to yield a secreted, biologically active form called Hh-N
(7-9). It is currently thought that intracellular Hh signaling is
triggered by the binding of Hh-N to the cell-surface receptor Patched
(Ptc), relieving Ptc's inhibitory effect on another cell-surface
molecule, Smoothened (Smo). Thus liberated, Smo appears to evoke
further, as yet unknown signaling events, leading to the
transcriptional activation of Hh target genes such as ptc, decapentaplegic, and wingless (3).
Genetic and biochemical studies of the intracellular signaling
mechanisms used by Drosophila Hh have established that a
zinc-finger transcription factor, Cubitus interruptus (Ci), plays a
critical role in Hh-triggered gene activation. Ci forms a large
multiprotein complex together with other Hh-signaling molecules,
including a putative protein-serine/threonine kinase, Fused (Fu), a
kinesin-related protein, Costal-2 (Cos2), and probably also Suppressor
of fused (Su(fu)) (10-15). In the absence of the Hh signal, this
complex associates with microtubules, presumably via Cos2, and appears to be involved in targeting Ci for proteolytic processing to yield a
75-kDa transcriptional repressor form called Ci75 (3, 10, 16). Upon
stimulation by Hh, the multiprotein complex dissociates from the
microtubules, and an uncleaved but activated form of Ci is translocated
into the nucleus to activate target genes.
Recent studies have demonstrated that the Hh signal regulates Ci
function through several distinct mechanisms (17-19). In cells that
are not exposed to Hh-N, the full-length form of Ci (Ci155) is
phosphorylated at multiple serine residues by protein kinase A
(PKA)1 and proteolytically
processed into the Ci75 repressor in a proteasome-dependent manner (18, 20-24). Hh signaling appears to reduce the
PKA-dependent phosphorylation, inhibiting the proteolytic
processing and stabilization of Ci155 (18). Another critical step for
Ci regulation is the translocation of Ci155 to the nucleus. It has been
shown that the Hh signal stimulates the nuclear translocation and
accumulation of Ci155 (18, 19, 25). In the absence of Hh, Su(fu)
appears to inhibit the nuclear translocation of Ci by tethering it in the cytoplasm; the Hh signal may release Ci from this sequestration (18, 26). The mammalian counterparts of Ci and Su(fu), known, respectively, as Gli and Su, seem to use similar mechanisms (27-29). Cos2 is also thought to play a role in regulating the nuclear translocation of Ci (15). An additional mechanism has been proposed, in
which Hh stimulates the transition of Ci155 from a relatively stable,
inactive form to a short-lived, transcriptionally active form (30).
This transition, also called maturation, of Ci may be regulated by the
action of Fu under the control of the Hh signal (18, 19, 30), although
the biochemical basis of this transition is still unclear.
It has been shown that Hh regulates the phosphorylation of downstream
signaling proteins, including Fu (31), Cos2 (10), Ci (18, 20, 21), and
Smo (32). The phosphorylation of Fu and Smo is induced upon Hh
stimulation and appears to represent the active state of these proteins
(31-33). Little is known, however, about the biological significance
of or the regulatory mechanisms underlying the phosphorylation of these
Hh-signaling proteins, except for the PKA-mediated Ci phosphorylation
described above. Fu has a typical domain structure for a
protein-serine/threonine kinase in its N terminus and has been shown to
positively regulate Hh signaling (30, 34, 35). Although the
significance of the kinase domain in Hh signaling has been established
genetically (36, 37), there is no biochemical evidence indicating that Fu has an intrinsic protein-phosphotransferring activity. Recently, a
putative human homolog for Fu was identified (38). The protein kinase
domain of human Fu (hFu) shares a high level of homology with that of
Drosophila Fu, but little homology was found between their
C-terminal domains (38).
To elucidate the role of Fu in Hh signaling and Ci activation, it is
necessary to analyze the biochemical function of Fu in Ci-dependent transcriptional activation. Previous work
indicated that the Hh signal is at least partially transduced in
Schneider 2 (S2) cells, because the phosphorylation of Fu is induced by Hh stimulation (31). Here we show that S2 cells have the potential to
transduce Hh-triggered intracellular signals to activate target gene
transcription when Ci protein is provided exogenously. Using S2 cells
transfected with a Ci expression vector and a luciferase-reporter construct, we investigated the mode of action of the Fu protein kinase
in Hh signal transduction, and found that forced expression of Fu
increased the transcription of the reporter gene. Mutational analysis
of the functional domain of Fu suggested that threonine 158 in the
activation segment is essential for Fu kinase activity and may be
involved in the activating phosphorylation induced by Hh signaling.
 |
EXPERIMENTAL PROCEDURES |
Construction of Expression and Reporter
Plasmids--
Drosophila Ci and Hh cDNAs were
generously provided by Drs. R. A. Holmgren and T. Tabata,
respectively. Double-stranded cDNAs for Fu (34), Su(fu) (39), and
Cos2 (11) were obtained by the reverse transcriptase-primed polymerase
chain reaction (PCR) using poly(A)+ RNA extracted from S2
cells and primer sets for each molecule. The PCR products were cloned
into the pBluescript plasmid, and several independent clones were
sequenced to exclude cDNA clones containing PCR-derived mutations.
The amino acid sequences encoded by these Cos2 and Su(fu) cDNAs
were identical to those of AAF59270 and AAF54852, respectively, in the
NCBI protein data base. The amino acid sequence of the Fu cDNA was
identical to that of AAF48871 except for a single amino acid
substitution of methionine 9 to a leucine residue in our Fu cDNA,
which seemed to be a natural polymorphism.
To construct expression plasmids for epitope-tagged proteins, a DNA
fragment encoding the Flag (MDYKDDDDKAGVD), HA
(MVYPYDVPDYASLVD), or Myc (MEQKLISEEDLGDPAG)
sequence was ligated to the 5' end of the coding region of Ci, Fu,
Su(fu), or Cos2 cDNA, and inserted into the expression vector
pAct5C0, which carries the Drosophila actin 5C promoter (40,
41). These plasmids were designated as pDA-Flag-Ci, pDA-Flag-Fu,
pDA-HA-Su(fu), and pDA-Myc-Cos2. The C-terminally truncated Fu mutants,
C1 (1) and C2 (1), were constructed by digesting the Fu
cDNA with NheI and NruI, respectively, followed by the ligation of a synthetic stop codon to the 3' end. The
KD (256) mutant was constructed by deleting a portion of the Fu
coding region of the pDA-Flag-Fu plasmid (amino acids (aa) 1-255). The
kinase-inactive KA3 mutant was constructed by mutating three lysine
residues (Lys-28, Lys-33, and Lys-37) to alanine residues by
recombinant PCR, as described previously (42, 43). Similarly, Asp-125
and Asn-130 in Fu were replaced by alanine residues to yield the
kinase-inactive DANA mutant. Other Fu mutants with a point mutation(s)
at Thr-158 and/or Ser-159 (TA, AS, AA, DS, ES, TD, TE, DD, DE, ED, and
EE) were also generated by recombinant PCR.
To construct the Hh-N-Flag expression plasmid (pDA-Hh-N-Flag), a DNA
fragment encoding the Hh-N portion with its N-terminal signal sequence
(8) was prepared by PCR, using the full-length Hh cDNA as the
template, ligated to a double-stranded oligonucleotide for a C-terminal
Flag tag (EFDYKDDDDK), and inserted into the pAct5C0 plasmid.
Two firefly luciferase reporter plasmids, ptc 136-Luc and
ptc 136-mut (18), which contain a wild-type and mutated
ptc promoter, respectively, were generously provided by Dr.
P. A. Beachy. A control reporter plasmid for the expression of
Renilla luciferase (pDA-RL) was constructed by inserting the
Renilla luciferase cDNA from the pRL-SV40 vector
(Promega) into the pAct5C0 plasmid.
Production and Partial Purification of Hh-N-Flag--
The S2
cells and S2 transfectants were maintained at 24 °C in DES medium
(Invitrogen) supplemented with 10% fetal calf serum (FCS). S2 cells
(6 × 106 cells/6-cm dish) were co-transfected with 36 µg of pDA-Hh-N-Flag and 4 µg of pACThyg (44) plasmids, using the
calcium phosphate co-precipitation method with Bes-buffered saline
(45), and transfected cells were selected using hygromycin B (0.3 mg/ml) resistance. The stable transfectants expressing Hh-N-Flag
(designated as S2HhNF cells) were propagated to a density of 1 × 106 cells/ml, fed with fresh medium containing 10% FCS and
0.3 mg/ml hygromycin B, and harvested at day 6 to obtain the
conditioned medium. The S2HhNF-conditioned medium was used as crude
Hh-N-Flag to stimulate S2 cells in the luciferase assay. An S2 cell
line that was established by transfection with pACThyg alone was
cultured in parallel, and the 6-day-old culture medium was used as a control.
For the experiments in Figs. 1E and 2B, Hh-N-Flag
protein was partially purified and concentrated. In brief, 2 ml of
anti-FLAG M2 affinity gel (Sigma) was added to 600 ml of the
conditioned medium from S2HhNF cells, mixed by gentle rotation for
2 h at 4 °C, and recovered by centrifugation at 1,500 × g for 10 min. The affinity resin was washed twice with 10 ml
of phosphate-buffered saline (PBS), and the Hh-N-Flag protein was
eluted with 2 × 6 ml of PBS containing 0.01% bovine serum
albumin and 100 µg/ml FLAG peptide (Sigma). The eluted fractions were
combined and concentrated to 1.8 ml using a Centriprep YM-10
ultrafiltration device (Millipore).
Cell Culture and Transfection--
S2 cells expressing the
hyg resistance gene (see above) were used throughout this
study for the luciferase assay, as the S2HhNF conditioned medium, which
was used for Hh-N stimulation, contained hygromycin B. Cells were
plated in a 24-well dish (3.75 × 105 cells/well) and
transfected with a plasmid mixture, using the calcium phosphate
co-precipitation method. Typically, 25 ng of pDA-Flag-Ci and 25 ng of
ptc 136-Luc plasmids were transfected together with other effector
expression constructs. The total amount of plasmid DNA used for each
transfection was adjusted to 2.5 µg by adding the vector plasmid
(pAct5C0). At 8 h after transfection, the medium was changed to
0.6 ml/well of fresh DES medium with 10% FCS, and 0.15 ml of the
S2HhNF conditioned medium or the control conditioned medium. After the
cells were incubated at 24 °C for 36 h, they were washed with
PBS and lysed in 250 µl of lysis buffer (25 mM
Tricine-NaOH (pH 7.8), 0.5 mM EDTA, 0.54 mM
Na3PO4, 16.3 mM MgSO4,
0.3% Triton X-100, and 6.5 mM dithiothreitol) (46). For
the firefly luciferase assay, 20 µl of the lysate was mixed with 380 µl of the above lysis buffer containing 1.2 mM ATP, 270 µM coenzyme A, and 50 µM luciferin at room
temperature, and the luminescence was immediately quantified.
Renilla luciferase activity was measured using the Dual
Luciferase Reporter Assay System (Promega). The error
bars in the figures indicate standard errors of the mean
(S.E.) of two independent transfection experiments.
Immunoprecipitation and Western Blotting--
S2 cells
were grown in a six-well plate (3 × 106 cells/well)
and transfected with 20 µg of plasmid DNA as described above. At
12 h after transfection, the medium was changed to fresh DES medium with 10% FCS. The cells were then incubated at 24 °C for 48 h, washed with ice-cold PBS, and lysed in 0.3 ml of Nonidet P-40 lysis buffer (50 mM Hepes-NaOH (pH 7.4), 150 mM NaCl, 1% Nonidet P-40, 10% glycerol, 1.5 mM MgCl2, 1 mM EGTA, 20 mM NaF, 20 mM -glycerophosphate, 1 mM dithiothreitol, 1 mM
p-amidinophenylmethylsulfonyl fluoride, 10 kallikrein-inactivating units/ml aprotinin, and 10 µg/ml leupeptin).
The supernatant was recovered after centrifugation at 20,000 × g for 10 min at 4 °C.
For Western blot analysis, cell lysates were fractionated by
SDS-polyacrylamide gel electrophoresis and transferred to a
polyvinylidene difluoride membrane filter (Immobilon-P, Millipore).
Blotting was performed with monoclonal antibodies specific for Flag
(M5, Sigma) and Myc (9E10, Zymed Laboratories Inc.)
epitopes or with the mouse anti-Ci monoclonal antibody (2A1, kindly
provided by Dr. R. A. Holmgren) (47, 48). The secondary antibody
was horseradish peroxidase-conjugated anti-mouse IgG antibody (Dako),
and the immunolabeled bands were detected using the enhanced
chemiluminescence detection system.
For immunoprecipitation of Flag-tagged protein, 25 µl of anti-FLAG M2
affinity gel (Sigma) was added to 0.3 ml of cell lysate, incubated for
2 h at 4 °C with gentle rotation, and washed five times with 1 ml of Nonidet P-40 lysis buffer for each washing step.
Immunoprecipitation of Myc-tagged protein was carried out similarly,
using 5 µg of anti-Myc (PL14, MBL) monoclonal antibody and 25 µl of
protein G-Sepharose beads (Amersham Pharmacia Biotech). For Western
blot analysis of the immunoprecipitated proteins, biotinylated
antibodies for the Flag (M5, Sigma) and Myc (9E10, BAbCO) epitopes were
used together with horseradish peroxidase-streptavidin (Roche Molecular
Biochemicals).
 |
RESULTS |
Hh-dependent Transcriptional Activation of a ptc
Reporter Gene in S2 Cells--
We tested Hh-triggered signal
transduction in S2 cells using a reporter construct (ptc 136-Luc)
that contained a ptc promoter region and firefly luciferase
cDNA (18). When the reporter construct alone was transfected into
S2 cells, no activation was observed even after Hh-N stimulation (Fig.
1B). We presumed that the
inability of S2 cells to respond to Hh might be due to the lack of Ci
expression (Fig. 1A), because S2 cells seem to express most
of the known Hh-signaling molecules except for Ci (10, 16, 31, 32). We
therefore examined the effect of forced expression of Ci on the
reporter activity. Transient transfection of S2 cells with an
expression plasmid encoding Flag epitope-tagged Ci cDNA resulted in
the production of full-length Ci protein (Ci155), which was detected by
Western blot analysis using anti-Ci (2A1) and anti-Flag antibodies
(Fig. 1A). We found that cotransfection of the
ptc reporter with the Ci expression plasmid increased the
basal luciferase activity, and that stimulation of the co-transfected
cells with Hh-N further enhanced the reporter activity (Fig.
1B). A mutant reporter construct (ptc 136-mut) in which
the three Ci-binding sites were mutated did not show any response to Ci
expression or Hh stimulation, indicating that the induction of the
luciferase gene was mediated by the binding of the exogenously
expressed Ci protein to the promoter element. An internal control
plasmid that expressed Renilla luciferase under the actin 5C
promoter produced the same levels of activity irrespective of Ci
expression or Hh stimulation (Fig. 1C).

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 1.
Hh-dependent transcriptional
activation of a Ptc reporter gene in S2 cells. A, S2
cells were transfected with pAct5C0 vector (( )) or
pDA-Flag-Ci plasmid (Ci), and the cell lysates were analyzed
by Western blotting using an anti-Ci (2A1) or anti-Flag (M5) monoclonal
antibody. B and C, S2 cells (3 × 106 cells/35-mm dish) were co-transfected with 2 µg of
firefly luciferase reporter plasmid (ptc 136-Luc or ptc 136-mut),
18 µg of pAct5C0( ) or pDA-Flag-Ci, and 0.2 µg of
Renilla luciferase reporter plasmid (pDA-RL), and then
cultured in the presence (20% S2HhNF-conditioned medium) or absence
(20% S2-conditioned medium) of Hh-N-Flag. Cells were lysed 48 h
after Hh-N stimulation, and the firefly luciferase (B) and
Renilla luciferase (C) activities were assayed as
described under "Experimental Procedures." The results are
represented as relative luminescence units (RLU).
D, S2 cells grown in a 24-well plate (3.75 × 105 cells/well) were transfected with the ptc 136-Luc
reporter plasmid (25 ng) and the indicated amounts of pDA-Flag-Ci
plasmid, cultured in the presence (Hh-N) or absence
(( )) of the S2HhNF-conditioned medium for 36 h, and
subjected to the firefly luciferase assay. E, S2 cells were
transfected with 2.5 µg of pAct5C0 vector, 25 ng of ptc 136-Luc,
and 25 ng of pDA-Flag-Ci (+ Ci) or pAct5C0 ( Ci). At 8 h after transfection, the cells were fed with
fresh medium, then stimulated with the indicated amounts (0-20%) of
the partially purified Hh-N-Flag. After the cells were incubated for
36 h, luciferase activity in the cell lysates was measured.
|
|
Previous studies showed that the expression of Ci in cultured
Drosophila cells resulted in reporter activation without Hh stimulation (18, 20, 49). Indeed, Ci expression increased the basal
reporter activity in a dose-dependent manner, but Hh stimulation produced an additional 2-4-fold increase at any Ci dosage
tested (Fig. 1D). We also examined the dosage effect of Hh-N
on the reporter activation (Fig. 1E). Stimulation of the Ci-transfected S2 cells with Hh-N increased the luciferase expression in a dose-dependent but saturable manner. In the absence of
Ci, however, even the highest concentration of Hh-N used in this assay failed to activate the reporter gene, indicating that the
ptc reporter activation was strictly dependent on Ci and
reflected the extent of Hh signaling. These results demonstrated that
the S2 cell line, when supplemented with Ci, has the ability to
transduce the Hh signal, leading to transcriptional activation of a
target gene.
Forced Expression of Fu Enhances Ci-mediated Reporter
Activation--
Previous genetic studies have implicated Cos2 and
Su(fu) in the negative regulation of Hh-triggered gene activation and
suggested that Fu plays a positive role (3). To test whether these
components could regulate the ptc reporter transcription in
the Ci-supplemented S2 cells, expression constructs for the
N-terminally tagged proteins, Myc-Cos2, HA-Su(fu), or Flag-Fu, were
co-transfected into S2 cells together with the Flag-Ci expression
plasmid and ptc 136-Luc reporter gene. As seen in Fig.
2A, co-expression of Cos2 or
Su(fu) resulted in reduction of the Hh-induced reporter activation. The
exogenous expression of Fu, in contrast, significantly increased the
reporter activity. The effect of Fu expression was observed only in the Hh-stimulated cells, not in the untreated cells, suggesting that the
activation of Fu was dependent on Hh. To better characterize the effect
of Fu expression, we examined the reporter activity in response to
various doses of Hh-N stimulation. At any Hh-N concentration tested,
cotransfection of Fu with Ci resulted in a 2-3-fold increase in
luciferase activity, compared with Ci transfection alone (Fig.
2B). In the absence of Ci, expression of Fu alone did not
increase reporter activity, even at a saturating dosage of Hh-N.
Coexpression of Fu and Ci caused no activation of the mutant reporter
(ptc 136-mut, data not shown). These results indicate that the
overexpression of Fu enhanced the Hh-triggered signal transduction by
regulating the function of Ci.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 2.
Effects of Hh-signaling molecules on
ptc reporter expression. A, S2 cells
grown in a 24-well plate (3.75 × 105 cells/well) were
transfected with the ptc 136-Luc reporter (25 ng) and pDA-Flag-Ci
plasmid (25 ng), together with 2.5 µg of the effector construct,
pAct5C0 (vector), pDA-Flag-Fu, pDA-HA-Su(fu), or pDA-Myc-Cos2 and
cultured in the presence (Hh-N) or absence (( ))
of the S2HhNF-conditioned medium, and subjected to the firefly
luciferase assay as described under "Experimental Procedures."
B, S2 cells were transfected with ptc 136-Luc (25 ng) and
the indicated combinations of the expression plasmids, pDA-Flag-Ci (25 ng), and pDA-Flag-Fu (500 ng), stimulated with the partially purified
Hh-N-Flag (0-10%), and assayed for luciferase activity.
|
|
The Kinase Catalytic Activity Is Essential for Fu Function in Ci
Activation--
The Fu protein consists of an N-terminal protein
kinase domain and a C-terminal domain with no obvious homology to known
protein motifs (31, 37). To characterize the roles of these domains in
the Hh-triggered ptc reporter activation, we constructed
several mutant Fu proteins (Fig.
3A). The KA3 mutant carried
alanine substitutions of three lysine residues, the putative
ATP-binding lysine residue (Lys-33) and two neighboring lysine residues
(Lys-28 and Lys-37). The DANA mutant had two alanine substitutions of
Asp-125 and Asn-130, both of which are invariantly conserved among
members of the protein kinase superfamily and are involved in the
phosphotransfer reaction (50). Two C-terminally truncated mutants,
C1 and C2, lacked aa 523-805 and 306-805, respectively, whereas
KD was an N-terminally truncated mutant lacking just the kinase
catalytic domain (aa 1-255). All the Fu mutants carried an N-terminal
Flag tag, and their expression in transfected S2 cells was confirmed by
Western blot analysis using an anti-Flag antibody (see Fig.
4B). As seen in Fig.
3B, the two catalytically inactive (kinase-dead) mutants, KA3 and DANA, failed to enhance the Hh-triggered transcriptional activation of the reporter gene. An additional Fu mutant in which only
Lys-33 was replaced with a methionine residue was also inactive (data
not shown). Likewise, expression of the KD mutant did not increase
the reporter activity. On the other hand, C1 and C2 had an effect
on reporter activation similar to wild-type Fu. The positive effect of
these C-terminal deletion mutants on reporter activation was still
dependent on the kinase catalytic function, because versions of the
mutations that included an inactivating mutation in the kinase domain
( C1/KA3, C1/DANA, C2/KA3, and C2/DANA) were all inactive.
Together, these results indicate that the Fu kinase domain plays a
primary role in the Hh-dependent activation of target genes
in S2 cells and that its catalytic activity is essential for this
function.

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 3.
Mutational analysis of Fu function in
Hh-dependent ptc reporter activation.
A, structure of the wild-type and mutant Fu proteins. The
hatched region indicates the kinase domain (aa
1-255) and the N-terminal oval represents the Flag epitope
tag. Sites mutated by alanine substitution are indicated by
asterisks in the kinase domain. In addition to the mutants
shown, mutants made by combining the kinase-inactive mutants (KA3 and
DANA) and the C-terminal deletion mutants ( C1 and C2) were
constructed. B, S2 cells were transfected with ptc 136-Luc
(25 ng), pDA-Flag-Ci (25 ng), pAct5C0 plasmid as carrier (2 µg), and
the indicated Fu construct (500 ng). Lanes 1 and
2, pAct5C0 (vector (V)); lanes
3-8, full-length Fu expression constructs with the
wild-type (WT), KA3, and DANA kinase domain;
lanes 9-14, C1 constructs with the wild-type,
KA3, and DANA kinase domain; lanes 15-20, C2
constructs with the wild-type, KA3, and DANA kinase domain;
lanes 21 and 22, KD mutant. After
transfection, the cells were left unstimulated (( )) or
were stimulated with the S2HhNF-conditioned medium (Hh-N),
and the cell lysates were assayed for reporter expression.
|
|

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 4.
Physical and functional interaction of Fu
with Su(fu) and Cos2. A, S2 cells were transfected with
ptc 136-Luc (25 ng), together with the indicated mixture of
pDA-Flag-Ci (25 ng), pDA-Flag-Fu (500 ng), pDA-HA-Su(fu) (1 µg), and
pDA-Myc-Cos2 (1 µg). The reporter expression was quantified as
described under "Experimental Procedures." B, expression
of Flag-Fu and Myc-Cos2 proteins in S2 cells. Cells were transfected
with pDA-Myc-Cos2 and the indicated construct (wild-type or mutant
Flag-Fu, or the control Flag-Mnk1), and the cell lysates were analyzed
by Western blotting for the expression of Flag-tagged proteins and
Myc-Cos2, as described under "Experimental Procedures."
C, physical association of Fu and Cos2 in vivo.
Cell lysates from B were immunoprecipitated with anti-Myc
antibody (PL14, left panels) or with anti-FLAG M2
affinity gel (right panels), and the precipitated
proteins were analyzed by Western blotting using a biotiny- lated antibody for the FLAG (upper panels)
or Myc (lower panels) epitope. The positions of
the Flag-tagged proteins and Myc-Cos2 are indicated by the
arrowheads. (NS) indicates a nonspecific band.
D and E, dose-dependent inhibition of
Fu function by Cos2 and Su(fu). S2 cells were co-transfected with
ptc 136-Luc (25 ng), pDA-Flag-Ci (25 ng), pDA-Flag-Fu (wild-type,
C1, or C2; 500 ng), and the indicated amounts of pDA-Myc-Cos2
(D) or pDA-HA-Su(fu) (E). The reporter expression
was quantified as described under "Experimental Procedures."
|
|
Su(fu) and Cos2 Inhibit the Fu Function for Reporter Activation in
S2 Cells--
Genetic and biochemical studies have demonstrated that
three Hh signaling components, Fu, Su(fu), and Cos2, associate with Ci
to form a multiprotein complex (10, 12, 14, 15) and regulate Ci
function in Hh-dependent gene expression. Several lines of
evidence suggest that Su(fu) and Cos2 inhibit Ci function by tethering
it in the cytoplasm and/or by promoting its proteolytic processing in
conjunction with PKA, whereas Fu promotes Ci activity (15, 18, 19, 25,
26, 30, 51). The modes of action of these molecules within the protein
complex, however, are poorly understood. To assess the roles of Fu in
Hh-triggered Ci activation with respect to the function of Cos2 and
Su(fu), we examined the effect of Su(fu) and Cos2 on the
Fu-dependent activation of the ptc reporter
gene. Cotransfection of an expression plasmid encoding Su(fu) or Cos2
with the Fu construct resulted in strong inhibition of the
ptc reporter activation (Fig. 4A). The expression
of unrelated proteins such as Drosophila ICAD/DREP-1 (52)
and a human protein kinase, Mnk1 (45), did not inhibit the Fu-enhanced
reporter activity (data not shown). Because Cos2 and Su(fu) physically interact with Fu, presumably through its C-terminal region (10, 12,
14), it is possible that the Cos2 and Su(fu) proteins antagonize Fu
activity via direct binding to the C-terminal domain. To test this
possibility, we examined the physical association of transiently
expressed Flag-Fu with Myc-Cos2 or HA-Su(fu) in S2 cells, by
immunoprecipitation Western analysis (Fig. 4, B and C). Immunoprecipitation of Myc-Cos2 from the transfected
cell lysates resulted in co-precipitation of the full-length Flag-Fu and Flag- KD, but not of Flag- C1, Flag- C2, or Flag-Mnk1 (Fig. 4C, left panels). This result,
together with the reciprocal immunoprecipitation using an anti-Flag
antibody (right panels), indicates that the C
terminus of Fu (aa 523-805) associates physically with Cos2, as
suggested previously (10). In contrast, we were not able to detect a
physical association between HA-Su(fu) and any of the Flag-Fu
constructs, despite reasonably good expression of the transiently
transfected HA-Su(fu) in the S2 cells (data not shown). We then
examined the effect of Su(fu) and Cos2 on the reporter activation
mediated by C1 and C2. The expression of Cos2 inhibited the
reporter activation induced by any of the three Fu constructs with a
similar dose dependence (Fig. 4D), indicating that direct
association is not required for Cos2 to inhibit Fu function. Su(fu)
also showed dose-dependent inhibition against the three Fu
constructs, but C2 was less sensitive to Su(fu) than the others were
(Fig. 4E), suggesting that Su(fu) negatively regulates Fu
function at least in part through the region deleted in C2 (aa
306-522) in the C-terminal domain.
Thr-158 Is Essential for Fu Function and Likely to Be Involved in
the Activating Phosphorylation of Fu--
The above results
demonstrate that Fu plays a positive role in Hh signaling through its
kinase catalytic activity. This leads to a hypothesis that Hh
stimulation might activate the protein kinase activity of Fu, as seen
in cases of many protein kinases involved in growth
factor/cytokine signal transduction. If so, the Fu catalytic activity
might be regulated by the phosphorylation of amino acid residues in the
activation loop (also called the activation segment) in kinase
subdomain VIII (50, 53). This activating phosphorylation could be
performed by an upstream protein kinase or in an autocatalytic fashion.
To examine this hypothesis, we replaced Thr-158 and Ser-159 with
alanine, individually or in combination (Fig.
5A), because these residues
lie in the position corresponding to the activating phosphorylation
site(s) for many protein kinases. As shown in Fig. 5B,
mutation of Ser-159 of Fu (TA mutant) had no effect on the ability to
augment the Hh signal, whereas substitution of Thr-158 (AS) resulted in
the complete loss of the activity. The doubly mutated Fu (AA) was also
inactive. Similar results were obtained with the C1 and C2
constructs containing the same point mutations. These results clearly
indicate that Thr-158 is essential for Fu function in activating the
ptc reporter but Ser-159 is not, and suggest that
phosphorylation of Thr-158 may be involved in the activation of the
kinase catalytic activity of Fu by Hh stimulation.

View larger version (48K):
[in this window]
[in a new window]
|
Fig. 5.
Effects of Thr-158 or Ser-159 mutations on
the Fu function. A, structure of Thr-158/Ser-159
mutants. Each mutant is indicated by a one-letter
representation of the amino acid residues at 158 and 159. For example,
DE is a Fu construct with Thr-158 Asp and Ser-159 Glu mutations. B, S2 cells were transfected with
ptc 136-Luc (25 ng), pDA-Flag-Ci (25 ng), pAct5C0 (2 µg), and the
indicated Fu construct (500 ng). Lanes 1 and
2, pAct5C0 (vector (V)); lanes
3-10, wild-type (WT) and Thr-158/Ser-159
constructs in the full-length Fu backbone structure; lanes
11-22, wild-type, TA, and AS constructs combined with the
C1 (lanes 11-16) and C2 (lanes
17-22) deletion mutants. After transfection, cells were
left unstimulated (( )) or stimulated with the
S2HhNF-conditioned medium (Hh-N), and the cell lysates were
assayed for reporter expression. C, the Thr-158/Ser-159
mutants with acidic amino acid substitutions were tested for their
activity in Hh-dependent ptc reporter
activation, as in B. D, mutants that combined the
substitutions in C with the C-terminal deletion mutants
( C1 and C2) were constructed and tested for their activity in
Hh-dependent ptc reporter expression.
|
|
To test this possibility further, we mutated Thr-158 and Ser-159 to
acidic amino acid residues, aspartate and glutamate, singly or in
combination, in an attempt to mimic phosphorylated amino acid residues
(Fig. 5A). As seen in Fig. 5C, mutants with a
single Asp or Glu substitution at either position showed activity that was similar to or slightly weaker than the activity seen with wild-type
Fu. In contrast, the DE and ED mutants were twice as active as
wild-type Fu when stimulated with Hh-N. Interestingly, expression of DE
or ED increased the reporter activity even in the absence of Hh-N
stimulation, suggesting that these mutants are constitutively active
without the Hh signal, although Hh stimulation was still required to
activate the Ci-mediated reporter expression to its maximum level.
Furthermore, the introduction of the DE or ED mutation into the C1
and C2 constructs also resulted in increased basal and induced
activity (Fig. 5D).
Combining the DE and KA3 mutations resulted in a complete loss of the
transcription-enhancing activity of Fu (data not shown), indicating
that the effect of the DE mutation was still dependent on the kinase
catalytic activity of Fu. Collectively, these results strongly suggest
that the kinase catalytic activity of Fu is regulated through its
phosphorylation at Thr-158, at least in part. However, the
co-expression of either Cos2 or Su(fu) completely inhibited the
reporter activation caused by any Fu mutant (data not shown), suggesting that the constitutively active Fu does not predominate over
the inhibitory action of Cos2 and Su(fu) in Ci-mediated gene expression.
 |
DISCUSSION |
In this paper we describe our investigations into the function of
Fu in the Hh-triggered, Ci-dependent activation of a
ptc-luciferase reporter construct in S2 cells. We found that
S2 cells could transduce the Hh signal for the transcriptional
activation of the ptc gene only when supplemented with the
essential transcription factor Ci (Fig. 1). Moreover, the
ptc reporter activation is strictly dependent on Hh
signaling. These features suggest that S2 cells will be very helpful in
further investigations of the Hh-dependent regulation of Ci activity.
Functional Domains of Fu in Hh-triggered Ci Activation--
The
data presented here demonstrate that Fu stimulates Ci-mediated
transcription of the ptc reporter gene in S2 cells (Fig. 2).
This is the first report showing Fu function in
Hh-dependent gene activation in cultured
Drosophila cells. The stimulatory effect of Fu on the Hh
signal was absolutely dependent on the exogenously expressed Ci
protein, indicating that Fu requires Ci to exert its function.
Deletion of the Fu C-terminal domain did not alter its activity,
whereas deletion of the kinase domain resulted in the complete loss of
the activity. Furthermore, none of the kinase-dead mutants (KA3 and
DANA in the full-length, C1, and C2 constructs) showed any effect
on Hh-dependent reporter activation (Fig. 3). These results
demonstrate that the kinase catalytic activity of Fu is essential for
its stimulatory effect on Hh signaling in S2 cells. We showed a
physical interaction between Fu and Cos2 in S2 cells using
co-immunoprecipitation-Western analysis (Fig. 4). The full-length Fu
and KD mutant bound Cos2, and C1 did not, indicating that the
C-terminal region (523) is critical for the interaction with Cos2,
as suggested previously (10, 14). However, the expression of Cos2
strongly inhibited the Fu-mediated reporter activation, irrespective of
the existence of this C-terminal region. This result implies that the
C-terminal domain is not essential for the negative regulation of Fu
function by Cos2. In contrast, Su(fu) may antagonize Fu function partly
via the region (aa 306-436) in the C-terminal domain, because C2
was less sensitive to Su(fu) than C1, although we could not detect a
physical association between Fu and Su(fu) in S2 cells.
Our results demonstrated that the Fu C-terminal domain is dispensable
for reporter activation in S2 cells, but genetic studies have
unequivocally shown that the C-terminal domain is essential for Fu
function, i.e. the class II fu mutants, most of
which have a C-terminal deletion like C1 and C2, show the same
phenotype as the kinase-inactive class I and null mutants in the
wild-type background (36). Subsequent analyses of numerous
fu alleles have suggested that the Fu C-terminal domain is
involved in regulating the N-terminal catalytic domain (31). In
contrast, other studies have suggested that, in the absence of the Hh
signal, the Fu C-terminal domain regulates Ci stability and/or the
formation of the Ci75 repressor, independent of its kinase catalytic
function (26, 51). Recently, Murone and co-workers (38) identified a
putative human homolog of Fu and tested its function in the gene
activation mediated by the Gli family transcription factors. The
expression of human Fu stimulated Gli2-mediated transcription in
mammalian C3H10T1/2 cells. In contrast to our results with
Drosophila Fu, neither the kinase catalytic activity of
human Fu nor the kinase domain itself appeared to be required for Gli2
activation, but the C-terminal domain seemed to be responsible (38).
Although the reason for this apparent discrepancy between
Drosophila Fu and human Fu is not obvious, we note that the
analysis of hFu function was performed completely in the absence of Hh
stimulation, and therefore the authors might have observed a
kinase-independent function of the C-terminal domain in cells that were
not responding to the Hh signal. Taken together, these results and ours
suggest that the Fu C-terminal domain supports the integrity of the Hh signaling complexes containing Fu, Cos2, Su(fu), and Ci (10, 14, 51),
and also plays a role in regulating Ci function that is nearly
independent of its kinase activity in cells that do not receive the Hh signal.
Hh Activates Fu Function through Augmentation of the Kinase
Activity--
Our studies suggest that the Hh signal is mediated at
least in part through the activation of the catalytic activity of the Fu protein kinase. In S2 cells, the C2 mutant is as active as wild-type Fu and is still dependent on Hh stimulation, suggesting that
an upstream signaling event acts on the kinase domain and activates its
catalytic activity. A common mechanism for the regulated activation of
protein-serine/threonine kinases is the phosphorylation of one or more
Ser/Thr residues in the activation segment (50, 53). Analysis of
alanine substitution mutants of Thr-158 and Ser-159 indicated that
Thr-158 is essential for Fu activity and suggested that Fu kinase
catalytic activity may be regulated by phosphorylation at Thr-158 (Fig.
5). This hypothesis is further supported by the fact that the
introduction of acidic amino acid residues into this position augmented
both the basal and Hh-induced Fu activities in our reporter assay.
Although Ser-159 is unlikely to be essential as an site for activating
phosphorylation, the acidic substitution of both Thr-158 and Ser-159
was required for the generation of constitutively active mutants. A
single carboxyl residue may not fully mimic the dianionic
phosphothreonine residue, and an additional negative charge may be
required to generate an active conformation (53). The ptc
reporter was activated by co-transfection with the DE or ED mutants,
even in the absence of Hh-N, but the activity was further enhanced upon
Hh-N stimulation. This result suggests that some additional
modification, presumably the phosphorylation of other sites, may be
required for the full activation of the Fu protein kinase, or that some
other Fu-independent events, regulated by Cos2, Su(fu), or PKA, may
cooperate with Fu to activate Ci. Interestingly, the activating segment
including Thr-158 and Ser-159 is one of the most conserved regions
(75% amino acid identity) between the Drosophila and human
Fu amino acid sequences, suggesting that a similar
phosphorylation-dependent mechanism is conserved in the
activation of human Fu.
Possible Fu Function for Ci Regulation in Hh Signal
Transduction--
The data presented in this paper suggest that the Fu
protein kinase that is activated upon Hh stimulation phosphorylates
some target protein(s), leading to transcriptional activation by Ci. Recent studies have demonstrated that the Hh signal controls Ci function via at least two posttranslational mechanisms: the proteolytic conversion from the full-length Ci155 to a repressor, Ci75, which is
triggered by phosphorylation by PKA, and the active translocation and
accumulation of Ci155 into the nucleus, which is regulated by Su(fu)
and Cos2 (15, 18, 19, 25, 26). Several lines of evidence suggest that
Fu, in conjunction with Su(fu), is involved in Hh-dependent
nuclear transport (19, 26). If so, a possible target of phosphorylation
by Fu could be Su(fu), and Fu would oppose the action of Su(fu),
perhaps by promoting its dissociation from the Ci155 complex (30, 37).
Similarly, Fu may phosphorylate Cos2 and antagonize its negative role
in Ci regulation (3). However, the fact that co-expression of Cos2 or
Su(fu) strongly inhibits Fu (Fig. 4) may suggest that the catalytic
phosphorylation by Fu cannot completely account for the mechanism
of inactivation of these proteins, and suggests that the release of Ci
from negative regulation by these molecules may be a prerequisite for
Fu-mediated activation of Ci. There appears to be another
Hh-dependent mechanism for Ci regulation, which stimulates
its transition (also called maturation or activation) from the
relatively stable, inactive form of Ci155 into a short-lived,
transcriptional activator. Therefore, an alternative possibility is
that Fu is involved in this "activation" step of Ci155, which may
be independent of its translocation into the nucleus (18, 30). In this
scenario, Fu may directly phosphorylate Ci155 to modulate its
interaction with other transcriptional machinery, or indirectly
regulate the Ci activation via the phosphorylation of an unidentified
regulator of Ci.
In summary, we propose that the kinase catalytic domain of Fu is
activated by Hh-dependent phosphorylation at least on
Thr-158, and in turn phosphorylates target proteins to transduce the Hh signal for Ci activation. This activating phosphorylation of Fu could
be performed either by an upstream protein kinase or in an
autocatalytic fashion. A biochemical protein kinase assay is necessary
to unequivocally elucidate the function and regulatory mechanism for
Fu, but our attempts to measure the protein-phosphotransferring activity of Fu have been unsuccessful, as previously described for both
Drosophila and human Fu (10, 31, 38). We expect that the
development of constitutively active Fu mutants could help to solve
this difficulty and would be useful for elucidating the mechanisms of
Hh signal transduction leading to specific gene activation.
 |
ACKNOWLEDGEMENTS |
We are grateful to Drs. Doris P. von Kessler
and Philip A. Beachy (Johns Hopkins University School of Medicine,
Baltimore, MD) for ptc 136-Luc and ptc 136-mut, Dr. Tetsuya Tabata
(University of Tokyo, Tokyo, Japan) for the Hh cDNA, and Dr. Robert
A. Holmgren (Northwestern University, Chicago, IL) for the Ci cDNA
and 2A1 monoclonal antibody.
 |
FOOTNOTES |
*
This work was supported in part by grants-in-aid from the
Ministry of Education, Science, Sports and Technology of Japan.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Supported by a research fellowship from the Japan Society for the
Promotion of Science.
§
To whom correspondence should be addressed.
Tel.: 81-6-6879-3318; Fax: 81-6-6879-3319; E-mail:
fukunaga@genetic.med.osaka-u.ac.jp.
Published, JBC Papers in Press, August 8, 2001, DOI 10.1074/jbc.M105871200
 |
ABBREVIATIONS |
The abbreviations used are:
PKA, protein
kinase A;
S2, Schneider 2;
PCR, polymerase chain reaction;
FCS, fetal
calf serum;
PBS, phosphate-buffered saline;
aa, amino acid(s);
Bes, 2-[bis(2-hydroxyethyl)amino]ethanesulfonic acid.
 |
REFERENCES |
| 1.
|
Tabata, T.,
and Kornberg, T. B.
(1994)
Cell
76,
89-102[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Basler, K.,
and Struhl, G.
(1994)
Nature
368,
208-214[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Ingham, P. W.
(1998)
EMBO J.
17,
3505-3511[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Hammerschmidt, M.,
Brook, A.,
and McMahon, A. P.
(1997)
Trends Genet.
13,
14-21[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Goodrich, L. V.,
and Scott, M. P.
(1998)
Neuron
21,
1243-1257[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Toftgard, R.
(2000)
Cell. Mol. Life Sci.
57,
1720-1731[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Lee, J. J.,
von Kessler, D. P.,
Parks, S.,
and Beachy, P. A.
(1992)
Cell
71,
33-50[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Tabata, T.,
Eaton, S.,
and Kornberg, T. B.
(1992)
Genes Dev.
6,
2635-2645[Abstract/Free Full Text]
|
| 9.
|
Mann, R. K.,
and Beachy, P. A.
(2000)
Biochim. Biophys. Acta
1529,
188-202[Medline]
[Order article via Infotrieve]
|
| 10.
|
Robbins, D. J.,
Nybakken, K. E.,
Kobayashi, R.,
Sisson, J. C.,
Bishop, J. M.,
and Therond, P. P.
(1997)
Cell
90,
225-234[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Sisson, J. C.,
Ho, K. S.,
Suyama, K.,
and Scott, M. P.
(1997)
Cell
90,
235-245[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Monnier, V.,
Dussillol, F.,
Alves, G.,
Lamour-Isnard, C.,
and Plessis, A.
(1998)
Curr. Biol.
8,
583-586[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Aza-Blanc, P.,
and Kornberg, T. B.
(1999)
Trends Genet.
15,
458-462[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Stegman, M. A.,
Vallance, J. E.,
Elangovan, G.,
Sosinski, J.,
Cheng, Y.,
and Robbins, D. J.
(2000)
J. Biol. Chem.
275,
21809-21812[Abstract/Free Full Text]
|
| 15.
|
Wang, G.,
Amanai, K.,
Wang, B.,
and Jiang, J.
(2000)
Genes Dev.
14,
2893-2905[Abstract/Free Full Text]
|
| 16.
|
Aza-Blanc, P.,
Ramirez-Weber, F. A.,
Laget, M. P.,
Schwartz, C.,
and Kornberg, T. B.
(1997)
Cell
89,
1043-1053[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Methot, N.,
and Basler, K.
(1999)
Cell
96,
819-831[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Chen, C. H.,
von Kessler, D. P.,
Park, W.,
Wang, B.,
Ma, Y.,
and Beachy, P. A.
(1999)
Cell
98,
305-316[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Wang, Q. T.,
and Holmgren, R. A.
(2000)
Development
127,
3131-3139[Abstract]
|
| 20.
|
Chen, Y.,
Gallaher, N.,
Goodman, R. H.,
and Smolik, S. M.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
2349-2354[Abstract/Free Full Text]
|
| 21.
|
Chen, Y.,
Cardinaux, J. R.,
Goodman, R. H.,
and Smolik, S. M.
(1999)
Development
126,
3607-3616[Abstract]
|
| 22.
|
Price, M. A.,
and Kalderon, D.
(1999)
Development
126,
4331-4339[Abstract]
|
| 23.
|
Jiang, J.,
and Struhl, G.
(1998)
Nature
391,
493-496[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Wang, G.,
Wang, B.,
and Jiang, J.
(1999)
Genes Dev.
13,
2828-2837[Abstract/Free Full Text]
|
| 25.
|
Wang, Q. T.,
and Holmgren, R. A.
(1999)
Development
126,
5097-5106[Abstract]
|
| 26.
|
Methot, N.,
and Basler, K.
(2000)
Development
127,
4001-4010[Abstract]
|
| 27.
|
Kogerman, P.,
Grimm, T.,
Kogerman, L.,
Krause, D.,
Unden, A. B.,
Sandstedt, B.,
Toftgard, R.,
and Zaphiropoulos, P. G.
(1999)
Nat. Cell Biol.
1,
312-319[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Ding, Q.,
Fukami, S.,
Meng, X.,
Nishizaki, Y.,
Zhang, X.,
Sasaki, H.,
Dlugosz, A.,
Nakafuku, M.,
and Hui, C.
(1999)
Curr. Biol.
9,
1119-1122[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Stone, D. M.,
Murone, M.,
Luoh, S.,
Ye, W.,
Armanini, M. P.,
Gurney, A.,
Phillips, H.,
Brush, J.,
Goddard, A.,
de Sauvage, F. J.,
and Rosenthal, A.
(1999)
J. Cell Sci.
112,
4437-4448[Abstract]
|
| 30.
|
Ohlmeyer, J. T.,
and Kalderon, D.
(1998)
Nature
396,
749-753[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Therond, P. P.,
Knight, J. D.,
Kornberg, T. B.,
and Bishop, J. M.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
4224-4228[Abstract/Free Full Text]
|
| 32.
|
Denef, N.,
Neubuser, D.,
Perez, L.,
and Cohen, S. M.
(2000)
Cell
102,
521-531[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Ramirez-Weber, F. A.,
Casso, D. J.,
Aza-Blanc, P.,
Tabata, T.,
and Kornberg, T. B.
(2000)
Mol. Cell
6,
479-485[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Preat, T.,
Therond, P.,
Lamour-Isnard, C.,
Limbourg-Bouchon, B.,
Tricoire, H.,
Erk, I.,
Mariol, M. C.,
and Busson, D.
(1990)
Nature
347,
87-89[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Therond, P. P.,
Limbourg Bouchon, B.,
Gallet, A.,
Dussilol, F.,
Pietri, T.,
van den Heuvel, M.,
and Tricoire, H.
(1999)
Development
126,
4039-4051[Abstract]
|
| 36.
|
Preat, T.,
Therond, P.,
Limbourg-Bouchon, B.,
Pham, A.,
Tricoire, H.,
Busson, D.,
and Lamour-Isnard, C.
(1993)
Genetics
135,
1047-1062[Abstract]
|
| 37.
|
Therond, P.,
Alves, G.,
Limbourg-Bouchon, B.,
Tricoire, H.,
Guillemet, E.,
Brissard-Zahraoui, J.,
Lamour-Isnard, C.,
and Busson, D.
(1996)
Genetics
142,
1181-1198[Abstract]
|
| 38.
|
Murone, M.,
Luoh, S. M.,
Stone, D.,
Li, W.,
Gurney, A.,
Armanini, M.,
Grey, C.,
Rosenthal, A.,
and de Sauvage, F. J.
(2000)
Nat. Cell Biol.
2,
310-312[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Pham, A.,
Therond, P.,
Alves, G.,
Tournier, F. B.,
Busson, D.,
Lamour-Isnard, C.,
Bouchon, B. L.,
Preat, T.,
and Tricoire, H.
(1995)
Genetics
140,
587-598[Abstract]
|
| 40.
|
Thummel, C. S.,
Boulet, A. M.,
and Lipshitz, H. D.
(1988)
Gene (Amst.)
74,
445-456[CrossRef][Medline]
[Order article via Infotrieve]
|
| 41.
|
Angelichio, M. L.,
Beck, J. A.,
Johansen, H.,
and Ivey-Hoyle, M.
(1991)
Nucleic Acids Res.
19,
5037-5043[Abstract/Free Full Text]
|
| 42.
|
Ishizaka-Ikeda, E.,
Fukunaga, R.,
Wood, W. I.,
Goeddel, D. V.,
and Nagata, S.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
123-127[Abstract/Free Full Text]
|
| 43.
|
Fukunaga, R.,
Ishizaka-Ikeda, E.,
and Nagata, S.
(1993)
Cell
74,
1079-1087[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Kondo, T.,
Yokokura, T.,
and Nagata, S.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
11951-11956[Abstract/Free Full Text]
|
| 45.
|
Fukunaga, R.,
and Hunter, T.
(1997)
EMBO J.
16,
1921-1933[CrossRef][Medline]
[Order article via Infotrieve]
|
| 46.
|
Shibuya, H.,
Kohu, K.,
Yamada, K.,
Barsoumian, E. L.,
Perlmutter, R. M.,
and Taniguchi, T.
(1994)
Mol. Cell. Biol.
14,
5812-5819[Abstract/Free Full Text]
|
| 47.
|
Motzny, C. K.,
and Holmgren, R.
(1995)
Mech. Dev.
52,
137-150[CrossRef][Medline]
[Order article via Infotrieve]
|
| 48.
|
Slusarski, D. C.,
Motzny, C. K.,
and Holmgren, R.
(1995)
Genetics
139,
229-240[Abstract]
|
| 49.
|
Akimaru, H.,
Chen, Y.,
Dai, P.,
Hou, D. X.,
Nonaka, M.,
Smolik, S. M.,
Armstrong, S.,
Goodman, R. H.,
and Ishii, S.
(1997)
Nature
386,
735-738[CrossRef][Medline]
[Order article via Infotrieve]
|
| 50.
|
Hanks, S. K.,
and Hunter, T.
(1995)
FASEB J.
9,
576-596[Abstract]
|
| 51.
|
Alves, G.,
Limbourg-Bouchon, B.,
Tricoire, H.,
Brissard-Zahraoui, J.,
Lamour-Isnard, C.,
and Busson, D.
(1998)
Mech. Dev.
78,
17-31[CrossRef][Medline]
[Order article via Infotrieve]
|
| 52.
|
Mukae, N.,
Yokoyama, H.,
Yokokura, T.,
Sakoyama, Y.,
Sakahira, H.,
and Nagata, S.
(2000)
J. Biol. Chem.
275,
21402-21408[Abstract/Free Full Text]
|
| 53.
|
Johnson, L. N.,
Noble, M. E.,
and Owen, D. J.
(1996)
Cell
85,
149-158[CrossRef][Medline]
[Order article via Infotrieve]
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. M. Ambrus, B. N. Nicolay, V. I. Rasheva, R. J. Suckling, and M. V. Frolov
dE2F2-Independent Rescue of Proliferation in Cells Lacking an Activator dE2F1
Mol. Cell. Biol.,
December 15, 2007;
27(24):
8561 - 8570.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-H. Chen, N. Gao, T. Kawakami, and P.-T. Chuang
Mice Deficient in the Fused Homolog Do Not Exhibit Phenotypes Indicative of Perturbed Hedgehog Signaling during Embryonic Development
Mol. Cell. Biol.,
August 15, 2005;
25(16):
7042 - 7053.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Watanabe-Fukunaga, S. Iida, Y. Shimizu, S. Nagata, and R. Fukunaga
SEI family of nuclear factors regulates p53-dependent transcriptional activation
Genes Cells,
August 1, 2005;
10(8):
851 - 860.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ascano Jr. and D. J. Robbins
An Intramolecular Association between Two Domains of the Protein Kinase Fused Is Necessary for Hedgehog Signaling
Mol. Cell. Biol.,
December 1, 2004;
24(23):
10397 - 10405.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Stegman, J. A. Goetz, M. Ascano Jr., S. K. Ogden, K. E. Nybakken, and D. J. Robbins
The Kinesin-related Protein Costal2 Associates with Membranes in a Hedgehog-sensitive, Smoothened-independent Manner
J. Biol. Chem.,
February 20, 2004;
279(8):
7064 - 7071.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kasai, M. Takahashi, N. Osumi, S. Sinnarajah, T. Takeo, H. Ikeda, J. H. Kehrl, G. Itoh, and H. Arnheiter
The G12 family of heterotrimeric G proteins and Rho GTPase mediate Sonic hedgehog signalling
Genes Cells,
January 1, 2004;
9(1):
49 - 58.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Roessler and M. Muenke
How a Hedgehog might see holoprosencephaly
Hum. Mol. Genet.,
April 2, 2003;
12(90001):
R15 - 25.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ascano Jr., K. E. Nybakken, J. Sosinski, M. A. Stegman, and D. J. Robbins
The Carboxyl-Terminal Domain of the Protein Kinase Fused Can Function as a Dominant Inhibitor of Hedgehog Signaling
Mol. Cell. Biol.,
March 1, 2002;
22(5):
1555 - 1566.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|